Rhythm Pharmaceuticals Inc Earnings

The next earnings date for Rhythm Pharmaceuticals Inc is May 12, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Rhythm Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
05/12/2026	$-0.82

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Rhythm Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
03/04/2026	---	$-0.73	11.17%
11/11/2025	---	$-0.82	-19.29%
08/05/2025	---	$-0.75	-11.92%
05/05/2025	Before Market	$-0.81	62.50%
02/20/2025	Before Market	$-0.72	1.37%
11/05/2024	After Market	$-0.73	8.75%
08/06/2024	Before Market	$-0.69	2.82%
05/07/2024	Before Market	$-2.35	-8.80%
02/22/2024	Before Market	$-0.70	0.00%
11/07/2023	Before Market	$-0.76	-2.70%
08/01/2023	Before Market	$-0.82	-3.80%
05/02/2023	Before Market	$-0.92	-26.03%
03/01/2023	Before Market	$-0.75	7.41%
11/08/2022	Before Market	$-0.79	21.00%
08/02/2022	Before Market	$-0.89	6.32%
05/03/2022	Before Market	$-1.05	-3.96%
03/01/2022	Before Market	$-0.85	6.59%
11/02/2021	Before Market	$-0.70	13.58%
08/03/2021	Before Market	$-0.70	-2.94%
05/03/2021	Before Market	$-1.16	-486.67%
03/01/2021	Before Market	$-0.79	1.25%
11/02/2020	Before Market	$-0.77	3.75%
08/03/2020	Before Market	$-0.71	14.46%
05/04/2020	Before Market	$-0.78	7.14%
03/02/2020	Before Market	$-0.78	12.36%
11/01/2019	Before Market	$-1.04	2.80%
07/29/2019	After Market	$-1.24	-40.91%
05/03/2019	Before Market	$-0.84	-10.53%
03/08/2019	Before Market	$-0.74	-29.82%
11/09/2018	Before Market	$-0.52	-13.04%
08/08/2018	After Market	$-0.52	-8.33%
05/14/2018	Before Market	$-0.60	-33.33%
03/12/2018	After Market	$-0.41	10.87%
11/14/2017	Before Market	$-1.51	-277.50%
08/30/2017	---	$-0.41	---
05/24/2017	---	$-0.29	---

More About Rhythm Pharmaceuticals Inc

Website

https://rhythmtx.com

Country

USA

Full Time Employees

414

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, Bardet-Biedl and Alström syndrome, Prader-Willi syndrome, and hypothalamic obesity. It is in Phase 3 clinical trials for treating acquired hypothalamic obesity, congenital hypothalamic obesity, pro-opiomelanocortin (POMC) and LEPR insufficiency obesities, SRC1 deficiency obesity, and SH2B1 deficiency obesity; and in phase 2 clinical trails for the treatment of Prader-Willi syndrome and MC4R deficiency. The company is also developing bivamelagon, an investigational oral small molecule MC4R agonist that is in phase 2 clinical trial for the treatment of MC4R pathway diseases; and RM-718, a next generation MC4R peptide agonist that is in phase 1 clinical trial for the treatment of hypothalamic obesity. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

“Rhythm Pharmaceuticals Inc Earnings” Can Refer to the Rhythm Pharmaceuticals Inc Earnings Date

Some people say “Rhythm Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Rhythm Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Rhythm Pharmaceuticals Inc Stock on the Earnings Date

If you own Rhythm Pharmaceuticals Inc stock (RYTM) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Rhythm Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Rhythm Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Rhythm Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Rhythm Pharmaceuticals Inc earnings or anything else related to the stock market.